Morgan Stanley’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
|
|||||
|
2025
Q1 | $14.6M | Buy |
|
|||||
|
2024
Q4 | $17.8M | Sell |
|
|||||
|
2024
Q3 | $37.8M | Buy |
|
|||||
|
2024
Q2 | $19.7M | Sell |
|
|||||
|
2024
Q1 | $27.3M | Sell |
|
|||||
|
2023
Q4 | $53.8M | Buy |
|
|||||
|
2023
Q3 | $965K | Sell |
|
|||||
|
2023
Q2 | $1.29M | Buy |
|
|||||
|
2023
Q1 | $1.31M | Buy |
|
|||||
|
2022
Q4 | $747K | Sell |
|
|||||
|
2022
Q3 | $1.65M | Sell |
|
|||||
|
2022
Q2 | $1.57M | Sell |
|
|||||
|
2022
Q1 | $2.94M | Sell |
|
|||||
|
2021
Q4 | $4.45M | Buy |
|
|||||
|
2021
Q3 | $1.69M | Buy |
|
|||||
|
2021
Q2 | $98K | Buy |
|
|||||
|
2021
Q1 | $2K | Sell |
|
|||||
|
2020
Q4 | $510K | Buy |
|